The impact of varicella vaccination in the United States

Seminars in Pediatric Infectious Diseases

Volumn 16, Issue 1 SPEC.ISS., 2005, Pages 38-43

  Hambleton, Sophie ^a   Gershon, Anne A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE; LIVE VACCINE;

CAUSE OF DEATH; CHICKENPOX; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; HEALTH PROGRAM; HERPES VIRUS; HERPES ZOSTER; HOSPITALIZATION; HUMAN; METHODOLOGY; MORBIDITY; MORTALITY; REVIEW; RISK ASSESSMENT; UNITED STATES; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS STRAIN; WILD TYPE; ADULT; CHILD; DISEASE PREDISPOSITION; EPIDEMIC; VIRUS LATENCY;

ADULT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; HERPES ZOSTER; HUMANS; UNITED STATES; VIRUS LATENCY;

EID: 15744368239     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.spid.2004.09.010     Document Type: Article

References (69)

1. R.E. Hope-Simpson Infectiousness of communicable diseases in the household (measles, mumps, and chicken pox). Lancet 2 1952 549 554
2. M. Wharton The epidemiology of varicella-zoster virus infections. Infect Dis. Clin N Am 10 1996 571 581
3. A.H. Ross, E. Lencher, G. Reitman Modification of chickenpox in family contacts by administration of gamma globulin N Engl J Med 267 1962 369 376
4. H. Izurieta, P. Strebel, P. Blake Post-licensure effectiveness of varicella vaccine during an outbreak in a child care center JAMA 278 1997 1495 1498
5. P. LaRussa Clinical manifestations of varicella A.M. Arvin A.A. Gershon Varicella-Zoster Virus Virology and Clinical Management 2000 Cambridge University Press Cambridge 206 219
6. B. Law, C. Fitzsimon, L. Ford-Jones, J. McCormick, M. Riviere Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program-Active (IMPACT) Pediatrics 104 1999 7 14
7. N. Thiry, P. Beutals, P. Van Damme, E. Van Doorslaer Economic evaluation of varicella vaccination programmes a review of the literature PharmacoEconomics 21 1992 13 38
8. P. Meyer, J.F. Seward, A.O. Jumaan, M.J. Wharton Varicella mortality trends before vaccine licensure in the United States, 1970-1994 J Infect Dis 182 2000 383 390
9. K. Galil, C. Brown, F. Lin, J. Seward Hospitalizations for varicella in the United States, 1998-1999 Pediatr Infect Dis J I21 2002 931 935
10. G. Enders, E. Miller Varicella and herpes zoster in pregnancy and the newborn A.M. Arvin A.A. Gershon Varicella-Zoster Virus Virology and Clinical Management 2000 Cambridge University Press Cambridge 317 347
11. J.W. Gnann Jr., R.J. Whitley Clinical practice. Herpes zoster N Engl J Med 347 2002 340 346
12. S.L. Thomas, A.J. Hall What does epidemiology tell us about risk factors for herpes zoster 4 2004 26 33
13. R. Berger, G. Florent, M. Just Decrease of the lympho-proliferative response to varicella-zoster virus antigen in the aged Infect Immun 32 1981 24 27
14. D.H. Gilden, R. Wright, S. Schneck, J.M. Gwaltney, R. Mahalingam Zoster sine herpete, a clinical variant Ann Neurol 35 1994 530 533
15. E. Stratman Visceral zoster as the presenting feature of disseminated herpes zoster J Am Acad Dermatol 46 2002 771 774
16. W.J. Edmunds, M. Brisson, J.D. Rose The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales Vaccine 19 2001 3076 3090
17. S. Gourishankar, J.C. McDermid, G.S. Jhangri, J.K. Preiksaitis Herpes zoster infection following solid organ transplantation incidence, risk factors and outcomes in the current immunosuppressive era Am J Transplant 4 2004 108 115
18. Rowley A, Lakeman F, Whitley R,, et al. Rapid detection of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet 335:440-441, 190
19. K.G. Chant, E.A. Sullivan, M.A. Burgess, M.J. Ferson, J.M. Forrest, L.M. Baird, D.I. Tudehope, M. Tilse Varicella-zoster virus infection in Australia Aust N Z J Public Health 22 1998 413 418
20. M. Brisson, W.J. Edmunds Epidemiology of Varicella-Zoster Virus in England and Wales J Med Virol 70 Suppl 1 2003 S9 S14
21. C.R. MacIntyre, C.P. Chu, M.A. Burgess Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia Epidemiol Infect 131 2003 675 682
22. M. Takahashi Development of a live varicella vaccine--past and future Jpn J Infect Dis 53 2000 47 55
23. Y.J. Asano Varicella vaccine the Japanese experience Infect Dis 174 1996 S310 S313
24. R.G. Sharrar, P. LaRussa, S. Galea, S. Steinberg, A. Sweet, M. Keatley, M. Wells, W. Stephenson, A. Gershon The postmarketing safety profile of varicella vaccine Vaccine 19 2001 916 923
25. R.P. Wise, M.E. Salive, M.M. Braun, G.T. Mootrey, J.F. Seward, L.G. Rider, P.R. Krause Postlicensure safety surveillance for varicella vaccine JAMA 284 2000 1271 1279
26. A.A. Gershon, S. Steinberg, L. Gelb NIAID Collaborative Varicella Vaccine Study Group Live attenuated varicella vaccine efficacy for children with leukemia in remission JAMA 252 1984 355 362
27. F. Ghaffar, K. Carrick, B.B. Rogers, L.R. Margraf, K. Krisher, O. Ramilo Disseminated infection with varicella-zoster virus vaccine strain presenting as hepititis in a child with adenosine deaminase deficiency Pediatr. Infect Dis J 19 2000 764 766
28. A.A. Gershon Varicella vaccine rare serious problems--but the benefits still outweigh the risks J Infect Dis 188 2003 945 947
29. O. Levy, J.S. Orange, P. Hibberd, S. Steinberg, P. LaRussa, A. Weinberg, S.B. Wilson, A. Shaulov, G. Fleisher, R.S. Geha, F.A. Bonilla, M. Exley Disseminated varicella infection due to vaccine (Oka) strain varicella-zoster virus in a patient with a novel deficiency in natural killer cells J Infect Dis 188 2003 948 953
30. J.M. Kramer, P. LaRussa, W.C. Tsai, P. Carney, S.M. Leber, S. Gahagan, S. Steinberg, R.A. Blackwood Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child Pediatrics 108 2001 E39
31. Hambleton S, Gershon AA: Preventing Varicella-Zoster Disease. Clin Microbiol Rev, in press.
32. R. Weibel, B.J. Neff, B.J. Kuter, H.A. Guess, C.A. Rothenberger, A.J. Fitzgerald, K.A. Connor, A.A. McLean, M.R. Hilleman, E.B. Buynak, E.M. Scolnick Live attenuateed varicella virus vaccine efficacy trial in healthy children N Engl J Med 310 1984 1409 1415
33. R. Weibel, B. Kuter, B. Neff, C. Rothenberger, A. Fitzgerald, K. Connor, D. Morton, A. McLean, E. Scolnick Live Oka/Merck varicella vaccine in healthy children further clinical and laboratory assessment JAMA 254 1985 2435 2439
34. B. Kuter, H. Matthews, H. Shinefield, S. Black, P. Dennehy, B. Watson, K. Reisinger, L.L. Kim, L. Lupinacci, J. Hartzel, I. Chan Ten year follow-up of healthy children who received one or two injections of varicella vaccine Pediatr Infect Dis J 23 2004 132 174
35. B.J. Kuter, R.E. Weibel, H.A. Guess, H. Matthews, D.H. Morton, B.J. Neff, P.J. Provost, B.A. Watson, S. Starr, S. Plotkin Oka/Merck varicella vaccine in healthy children final report of a 2-year efficacy study and 7-year follow-up studies Vaccine 9 1991 643 647
36. C. Johnson, T. Stancin, D. Fattlar, L.P. Rome, M.L. Kumar A long-term prospective study of varicella vaccine in healthy children Pediatrics 100 1997 761 766
37. T. Varis, T.J. Vesikari Efficacy of high titer live attenuated varicella vaccine in healthy young children Infect Dis 174 1996 S330 S334
38. C.J. White, B.J. Kuter, C.S. Hildebrand, K.L. Isganitis, H. Matthews, W.J. Miller, P.J. Provost, R.W. Ellis, R.J. Gerety, G.B. Calandra Varicella vaccine (VARIVAX) in healthy children and adolescents results from clinical trials, 1987 to 1989 Pediatrics 87 1991 604 610
39. N. Takayama, M. Minamitani, M. Takayama High incidence of breakthrough varicella observed in healthy Japanese children immunized with live varicella vaccine (Oka strain) Acta Paedr Jpn 39 1997 663 668
40. M. Vazquez, P. LaRussa, A. Gershon, S. Steinberg, K. Freudigman, E. Shapiro The effectiveness of the varicella vaccine in clinical practice N Engl J Med 344 2001 955 960
41. M. Vazquez, P.S. LaRussa, A.A. Gershon, L.M. Niccolai, C.E. Muehlenbein, S.P. Steinberg, E.D. Shapiro Effectiveness over time of varicella vaccine JAMA 291 2004 851 855
42. D. Clements, S.P. Moreira, P. Coplan, C. Bland, E. Walter Postlicensure study of varicella vaccine effectiveness in a day-care setting Pediatr Infect Dis J 18 1999 1047 1050
43. E. Halloran, S. Cochi, T. Lieu, M. Wharton, L. Fehrs Theoretical epidemiological and morbidity effects of routine immunization of preschool children with varicella vaccine in the United States Am J Epidemiol 140 1984 81 104
44. Centers for Disease Control and Prevention Prevention of varicella Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 45 1996 1 36
45. J. Seward, K. Galil, M. Wharton Epidemiology of varicella A. Arvin A. Gerson Varicella-Zoster Virus Virology and Clinical Management 2000 Cambridge University Press Cambridge 187 205
46. T. Lieu, S. Cochi, S. Black, M.E. Halloran, H.R. Shinefield, S.J. Holmes, M. Wharton, E.J. Washington Cost-effectiveness of a routine varicella vaccination program for U.S. children Am Med Assoc 271 1994 375 381
47. Committee on Infectious Diseases Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Pediatrics 95 1995 791 796
48. Centers for Disease Control and Prevention Prevention of varicella. Update MMWR 48 1999 1 6
49. A. Gershon, N. Mervish, P. LaRussa, S. Steinberg, S.-H. Lo, D. Hodes, S. Fikrig, V. Bonagura, S. Bakshi Varicella-zoster virus infection in children with underlying HIV infection J Infect Dis 176 1997 1496 1500
50. Centers for Disease Control and Prevention National, State, and Urban Area Vaccination Coverage Among Children Aged 19-35 months - United States, 2003 MMWR 53 2004 658 661
51. J.F. Seward, B.M. Watson, C.L. Peterson, L. Mascola, J.W. Pelosi, J.X. Zhang, T.J. Maupin, G.S. Goldman, L.J. Tabony, K.G. Brodovicz, A.O. Jumaan, M. Wharton Varicella disease after introduction of varicella vaccine in the United States, 1995-2000 JAMA 287 2002 606 611
52. D.A. Clements, J.I. Zaref, C.L. Bland, E.B. Walter, P. Coplan Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina Arch Pediatr Adolesc Med 155 2001 455 461
53. Centers for Disease Control and Prevention Decline in annual incidence of varicella-selected states, 1990-2001 MMWR 52 2003 884 885
54. U. Buchholz, R. Moolenaar, C. Peterson, L. Mascola Varicella outbreaks after vaccine licensure should they make you chicken Pediatrics 104 1999 561 563
55. M.S. Dworkin, C.E. Jennings, J. Roth-Thomas, J.E. Lang, C. Stukenberg, J.R. Lumpkin An outbreak of varicella among children attending preschool and elementary school in Illinois Clin Infect Dis 35 2002 102 104
56. K. Galil, E. Fair, N. Mountcastle, P. Britz, J. Seward Younger age at vaccination may increase risk of varicella vaccine failure J Infect Dis 186 2002 102 105
57. K. Galil, B. Lee, T. Strine, C. Carraher, A.L. Baughman, M. Eaton, J. Montero, J. Seward Outbreak of varicella at a day-care center despite vaccination N Engl J Med 347 2002 1909 1915
58. B.D. Tugwell, L.E. Lee, H. Gillette, E.M. Lorber, K. Hedberg, P.R. Cieslak Chickenpox outbreak in a highly vaccinated school population Pediatrics 113 2004 455 459
59. A. Ngai, B.O. Stahele, B.J. Kuter, N.M. Cyanovich, I. Cho, H. Matthews, P. Keller, A. Arvin, B. Wtson, C.J. White Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children Pediatr Infect Dis J 15 1996 49 54
60. I.S. Chan, S. Li, H. Matthews, C. Chan, R. Vessey, J. Sadoff, J. Heyse Use of statistical models for evaluating antibody response as a correlate of protection against varicella Stat Med 21 2002 3411 3430
61. S. Li, I. Chan, H. Matthews, J. Heyse, C. Chan, B. Kuter, K. Kaplan, R. Vessey, J. Sadoff Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection Pediatr Infect Dis J 21 2002 337 342
62. A. Gershon, S. Steinberg, L. Gelb NIAID Collaborative Varicella Vaccine Study Group Live attenuated varicella vaccine use in immunocompromised children and adults Pediatrics 78 1986 757 762
63. F. Zhou, A.O. Jumaan, A. Shefer, R. Harpaz Impact of varicella vaccination on health care utilization in the United States, 1994-2001 Pediatr Research 55 2004 200A abstract #1132-503
64. L. McCoy, F. Sovillo, P. Simon Varicella-related mortality in California, 1988-2000 Pediatr Infect Dis J 23 2004 498 503
65. M. Brisson, W.J. Edmunds, N.J. Gay Varicella vaccination impact of vaccine efficacy on the epidemiology of VZV J Med Virol 70 Suppl 1 2003 S31 S37
66. I.B. Hardy, A. Gershon, S. Steinberg, P. LaRussa The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia N Engl J Med 325 1991 1545 1550
67. G.S. Goldman Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage Vaccine 21 2003 4243 4249
68. G.S. Goldman Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community uder active surveillance Vaccine 21 2003 4238 4242
69. M.J. Levin Use of varicella vaccines to prevent herpes zoster in older individuals Arch Virol Suppl 17 2001 151 160